Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,941 | -29,047 | 2,611 | -72,850 | -34,757 |
| Depreciation Amortization | -1,398 | -255 | 790 | 1,073 | 537 |
| Income taxes - deferred | N/A | 3,620 | -3,857 | -2,609 | -1,315 |
| Accounts receivable | -2,741 | -1,385 | -10,797 | -389 | -404 |
| Accounts payable and accrued liabilities | 2,016 | -1,348 | 7,066 | 2,698 | -772 |
| Other Working Capital | -2,116 | 4,405 | 14,449 | 5,732 | 270 |
| Other Operating Activity | 7,394 | 24,332 | 19,697 | 8,146 | 6,435 |
| Operating Cash Flow | $-31,786 | $322 | $29,959 | $-58,199 | $-30,006 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,211 | -175,176 | -207,514 | 1,150 | 890 |
| PPE Investments | -475 | -602 | -2,322 | -2,056 | -487 |
| Investing Cash Flow | $-6,686 | $-175,778 | $-209,836 | $-906 | $403 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 413 | 880 | 715 | 446 | 241 |
| Financing Cash Flow | $413 | $880 | $715 | $446 | $241 |
| Exchange Rate Effect | -1 | -330 | -74 | 66 | 71 |
| Beginning Cash Position | 159,521 | 334,427 | 334,427 | 334,427 | 334,427 |
| End Cash Position | 121,461 | 159,521 | 155,191 | 275,834 | 305,136 |
| Net Cash Flow | $-38,060 | $-174,906 | $-179,236 | $-58,593 | $-29,291 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,786 | 322 | 29,959 | -58,199 | -30,006 |
| Capital Expenditure | -475 | -602 | -2,322 | -2,056 | -487 |
| Free Cash Flow | -32,261 | -280 | 27,637 | -60,255 | -30,493 |